Cancer Treatment Research in Washington
Cancer Treatment Research (93.395) awarded $236 million to recipients in Washington in 117 grants from fiscal 2021 to 2025, 4.3% of the program's national total. Fred Hutchinson Cancer Center received the most, $156 million.
- Awarded in Washington$236 million
- Awards117
- Share of the program4.3%
- Rank among states6th of 50
- National total$5.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 55 | $43.5 million |
| FY 2022 | 56 | $44.7 million |
| FY 2023 | 58 | $42.8 million |
| FY 2024 | 66 | $44.7 million |
| FY 2025 | 62 | $60.5 million |
Recipients in Washington
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Fred Hutchinson Cancer Center | Nonprofits | 57 | $156 million |
| University of Washington | Colleges and universities | 23 | $37.3 million |
| Seattle Children's Hospital | Nonprofits | 17 | $18.2 million |
| Cancer Targeted Technology LLC | Small businesses | 3 | $3.8 million |
| Syntrix Biosystems Inc. | Small businesses | 3 | $3.7 million |
| Avm Biotechnology, Inc. | Small businesses | 3 | $3.4 million |
| Institute for Systems Biology | Nonprofits | 1 | $3.0 million |
| Benaroya Research Institute at Virginia Mason | Nonprofits | 1 | $2.6 million |
| XL Sci-Tech Inc | Small businesses | 1 | $2.3 million |
| Pharmain Corporation | Small businesses | 1 | $2.0 million |
Open opportunities under this program
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
See all 47 on the program page
Questions people ask
How much Cancer Treatment Research money goes to Washington?
$236 million from fiscal 2021 to 2025, across 117 awards. Washington ranks 6th of 50 states and territories for this program.
Who receives Cancer Treatment Research money in Washington?
The largest recipient is Fred Hutchinson Cancer Center, with $156 million in 57 awards. Next are University of Washington and Seattle Children's Hospital.
Can organizations in Washington apply now?
Yes, 47 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Treatment Research in other states
Other large programs in Washington
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Federal Transit Formula Grants
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Temporary Assistance for Needy Families
- National School Lunch Program
- Federal Transit Capital Investment Grants
- Allergy and Infectious Diseases Research
- Child Care and Development Block Grant